Macquarie Group
XENT

Macquarie Group’s Intersect ENT, Inc XENT Stock Holding History

Macquarie Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-73,831
Closed -$1.4M – 1656
2016
Q1 		$1.4M Buy
73,831
+2,161
+3% +$39.1K ﹤0.01% 1042
2015
Q4 		$1.61M Buy
71,670
+16,381
+30% +$324K ﹤0.01% 991
2015
Q3 		$1.29M Buy
55,289
+2,562
+5% +$70.7K ﹤0.01% 1084
2015
Q2 		$1.51M Buy
52,727
+17,691
+50% +$464K ﹤0.01% 1094
2015
Q1 		$905K Buy
35,036
+683
+2% +$15.6K ﹤0.01% 1179
2014
Q4 		$637K Buy
34,353
+2,104
+7% +$37.9K ﹤0.01% 1226
2014
Q3 		$500K Buy
+32,249
New +$485K ﹤0.01% 1258

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Macquarie Group's XENT Position: Q2 2016 in Review

Macquarie Group sold out of Intersect ENT, Inc (XENT) in Q2 2016, closing a stake of 73,831 shares — an estimated $1.4M sold.

Macquarie Group first reported a position in XENT in Q3 2014 and held it in 7 quarters. The position peaked at $1.61M in Q4 2015. 100 funds tracked by Wall St. Rank hold XENT as of Q2 2016.

  • Macquarie Group reported no remaining Intersect ENT, Inc position as of Q2 2016 after selling out during the quarter.
  • Macquarie Group sold 73,831 Intersect ENT, Inc shares in Q2 2016, an estimated $1.4M.
  • Macquarie Group first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 7 quarters.
  • Macquarie Group's Intersect ENT, Inc position peaked at $1.61M in Q4 2015.
  • 100 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2016.

Based on Macquarie Group's 13F filing for Q2 2016, filed 15 Aug 2016.